alanyl-glutamyl-aspartyl-glycine has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khavinson, VKh; Kuznik, BI; Lin'kova, NS; Tarnovskaia, SI | 1 |
1 review(s) available for alanyl-glutamyl-aspartyl-glycine and Atherogenesis
| Article | Year |
|---|---|
[Peptides and CCL11 and HMGB1 as molecular markers of aging: literature review and own data].
Topics: Aging; Animals; Atherosclerosis; Base Sequence; Binding Sites; Biomarkers; Chemokine CCL11; Dipeptides; Gene Expression Regulation; HMGB1 Protein; Humans; Molecular Sequence Data; Neurodegenerative Diseases; Oligopeptides | 2014 |